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Abstract
Motivated by experimental observations in 3D/organoid cultures derived from glioblastoma,
we develop a mathematical model where tumour aggregate formation is obtained as the re-
sult of nutrient-limited cell proliferation coupled with chemotaxis-based cell movement. The
introduction of a chemotherapeutic treatment induces mechanical changes at the cell level, with
cells undergoing a transition from rigid bodies to semi-elastic entities. We analyse the influ-
ence of these individual mechanical changes on the properties of the aggregates obtained at
the population level by introducing a nonlinear volume-filling chemotactic system of partial
differential equations. The elastic properties of the cells are taken into account through the
so-called squeezing probability, which allows us to change the packing capacity of the aggregates,
depending on the concentration of the treatment in the extracellular microenvironment. We
explore two scenarios for the effect of the treatment: firstly, the treatment acts only on the
mechanical properties of the cells and, secondly, we assume it also prevents cell proliferation.
A linear stability analysis enables us to study the ability of the system to create patterns. We
provide numerical simulations in 1D and 2D that illustrate the shrinking of the aggregates due
to the presence of the treatment.
1 Introduction
Cell migration in the extracellular microenvironment (ECM) and the organisation of cells in response
to chemical and mechanical cues are successfully studied using continuum descriptions based on
differential equations [1, 42]. In a continuous setting, the chemotactic behaviour of cells (i.e. the
ability to move along a chemical gradient) is often modelled using a Keller-Segel system of equations
[27]. This model was originally proposed for pattern formation in bacterial populations but turned
out to be pertinent to describe a wide variety of self-organisation behaviours [11, 6, 60, 28, 57].
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Different variations of the Keller-Segel model have been adopted in order to better understand the
way cells aggregate [8, 4, 40, 47, 16].
Cancer cells have been shown to respond to chemical and mechanical signals from components of
the tumour micro-environment (TME) and vice versa, cells in the TME acquire a more tumourigenic
phenotype, which would sustain tumour growth. The interaction of tumour cells with the TME has
been the subject of recent biological surveys [22, 18]. Many in vitro (and ex vivo) experiments
have shown that cells that are cultured on ECM often have a tendency to form aggregate patterns
that are dependent on the particular cell lines and physical properties of the media [20]. The exact
consequences of the dynamic interplay between heterogeneous cellular entities and their response to
alterations in the TME have not yet been elucidated. In particular, little is known about the role
of mechanics in the spatial organization of the tumour spheroids. Biological evidence presented in
[33, 29, 12] suggests that the formation of aggregates in glioma cells can be explained through a
chemotaxis process, rather than, e.g., cell-cell adhesion. In this paper, we follow the chemotactic
approach to explain the formation of glioma aggregates. For the case of breast cancer cells, a recent
report [9] has proposed a chemotaxis-based explanation for spheroid formation based on theoretical
analysis and numerical simulations of the Turing instabilities of such systems.
Inspired by experimental observations in 3D/organoid cultures derived from freshly operated
Glioblastoma (GBM), which reproduce in vivo behaviours as described in [37] (see Section 2 for
more details), in this paper we explore a simple setting where GBM aggregate formation is the result
of nutrient-limited cell proliferation coupled with a chemotaxis-based cell movement. A chemother-
apeutic treatment introduced after the formation of the aggregates induces mechanical changes at
the cell level. We study the influence of these individual mechanical changes on the characteristics
of the aggregates obtained at the population level.
GBM are solid tumours characterised by intra- and inter-tumoural heterogeneity and resistance
to conventional treatments that result in a poor prognosis [31]. They are the most common and
aggressive primary brain tumour in adults. Standard treatments include surgical resection (when
possible), combined with radiotherapy and chemotherapy using the DNA alkylating agent Temo-
zolomide (TMZ) [49]. In fact, the overall survival of treated patients is about 15 months versus 3
months without treatment, with fewer than 5% of patients surviving longer than 5 years [48].
One reason behind this relative therapeutic failure is the poor response of GBM tumours to
this chemotherapeutic treatment due to their plasticity. Several studies have looked at the genetic
compounds of TMZ-resistant cells focusing on the genes responsible for DNA mismatch repair protein
[51], while other studies focused on spatial and temporal variations in signalling pathways, which
lead to functional and phenotypic changes in GBM [38]. The communication between the tumour
cells and the TME as well as the properties of the ECM have a large impact on tumour evolution
and invasion, as shown in recent studies [15, 7, 59]. From a biological and medical perspective,
it is difficult to investigate the connections between clinically observable glioma behaviour and
the underlying molecular and cellular processes. The challenge is to integrate the theoretical and
empirical acquired knowledge to better understand the mechanisms and factors that contribute to
GBM resistance to treatment. In this context, mathematical models provide useful tools towards
identifying dependencies between different phenomena and how they are affected by the different
therapeutic strategies.
Much effort has been dedicated to the modelling of GBM formation and invasion of the surround-
ing tissue, as well as to improving diagnosis and treatment. The exhaustive review [2] discusses
different modelling approaches as well as some of the main mechanisms that are observed in GBM
formation and invasion.
In this work, we explore two scenarios: the case where the treatment only acts on the mechanical
properties of the cells, and the case where it also prevents cell proliferation [30]. We adopt a macro-
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scopic approach where cells are represented by their macroscopic density and are supposed to move
in the environment via chemotaxis, i.e. towards zones of high concentrations of a chemoattractant
that is produced by the tumour cells. Moreover, cell proliferation is assumed to depend on the local
concentration of nutrients available. Finally, we suppose that when the treatment - represented by
its continuous concentration - is introduced, it diffuses in the environment and is naturally consumed
by the cells.
Under these hypotheses, which are motivated by the experimental results discussed in Section 2,
we obtain a nonlinear volume-filling Keller-Segel model for the cell density, coupled with reaction
diffusion equations for the chemoattractant and treatment concentrations. Moreover, we provide a
linear stability analysis that enables us to study the ability of the system to generate patterns, and
we provide numerical simulations in 1D and 2D.
The paper is organised as follows. In Section 2 we describe the in vitro experiments and the main
experimental observations that motivated our model. Section 3 is devoted to the description of the
model for the first part of the experiments (without the treatment, Section 3.1) and the second part,
when the treatment is introduced (Section 3.2). In Section 4, we present the stability analysis for
each of these two parts, and Section 5 is devoted to numerical simulations. Section 5.1 presents the
numerical scheme, Section 5.3 presents the results in 1D including a discussion on the comparison
between numerical experiments and theoretical predictions of the stability analysis. Section 5.4
shows the 2D simulations. Finally, we discuss the results and give some perspectives in Section 6.
2 Description of the experiments
To address the question of the response of GBM cells to TMZ treatment, we took advantage of
recently developed 3D biosphere experiments, using GBM patient-derived cultures in a simple 3D
scaffold composed of alginate and gelatin [39]. GBMG5 cells were cultured at a concentration of
4×106 cells/ml for 14 days until the formation of cell aggregates could be observed, corresponding to
the first part of the experiments (P1). After that, the cultures were treated with 100 µM TMZ for
two hours once every week (second part of the experiments, P2). Over the 30 days, the proliferation
was determined counting 3 representative samples, and the cell number was determined as follows.
The biospheres were dissociated by incubation for 3 min in 100 mM Na-Citrate and the cell number
and cell viability were determined using the Countess optics and image automated cell counter (Life
Technologies). In addition the aggregates were photographed to analyse their morphology, and
the diameter of the cell aggregates were measured from pictographs using FIJI. To determine the
diameters of these cell structures, more than 200 cell aggregates were measured.
We show in Figure 1 (I) the mean length (in µm) of the cell aggregates computed from the
microscopic images without TMZ treatment (round markers), and with TMZ weekly administered
(squared markers). Figures 1 A and B show typical microscopic images of the spheroids at day 24,
without and with weekly TMZ treatment respectively. In Figure 1 (II), we show the evolution of
the cell number as a function of time, where we do not observe big changes in cell number with and
without TMZ, once the carrying capacity of the system is reached.
Using clinically relevant concentrations [44] the total number of cells in the biospheres does not
seem to be significantly impacted by the TMZ treatment. However, the mean size of the GBMG5
cell aggregates decreases when TMZ is introduced weekly as compared to control cultures (Figure 1
(I)), suggesting that in the presence of the treatment, GBMG5 cells tend to self-organize into smaller
and more compact cell clusters.
Another observation supporting a tendency for GBM cells to form more compact structures with
higher intracelluar adhesion under this type of treatment is the increased expression of claudin, a
3
Figure 1: Biological experiments of GBMG5 cells cultured in 3D scaffolds with or without 100µM
TMZ. (I) Evolution of the mean cell aggregates diameter determined from the microscopic images as
function of time, without treatment (circle markers) and with a weekly TMZ (square markers). (A)
Typical microscopic image on day 24 of control cell aggregates without treatment, (B) microscopic
image at day 24 with 100µM of TMZ administrated weekly for 2 hours. (II) Evolution of the total
cell number in the biospheres as function of time, without treatment (circle markers) and with weekly
TMZ (square markers).
Figure 2: Claudin expression marking the tight junctions between the cells.
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marker of tight junctions formed between cells (Figure 2). In Figure 2 we have GBMG5 cells that
were cultured for 14 days until the formation of cell aggregates could be observed, and the cultures
were treated with different doses of TMZ until day 23. Furthermore, cell aggregates were fixed then
labeled with an anti-claudin antibody. The degree of staining was determined in a double-blind
experiment. As one can observe from the images of Figure 2 (left), the cell aggregates seem to be
smaller and more compact when TMZ is present compared to the control group (top left figure),
and these cultures are associated with higher levels of claudin (see Figure 2 (right)).
Inspired by these observations and results presented in [33, 29, 12], we propose a general model
for the chemotaxis-driven formation of cell clusters and shrinking of the aggregates via the action of
a non-cytotoxic drug whose effect would be characterised by a change in the mechanical properties of
cells that would just modify their packing properties. Moreover, we also consider a second scenario
where the treatment would also affect cell proliferation and compare the results obtained.
3 Mathematical model
Motivated by the experiments described in Section 2, we assume that glioma cells have a chemotactic
behavior, i.e. they move in response to some signaling chemical (chemoattractant), which is secreted
by themselves and diffuses in the environment. The chemotactic movement of cell populations plays
a fundamental role for example in gastrulation [17], during embryonic development; it directs the
movement of immune cells to sites of infection and it is crucial to understand tumour cell invasion [14]
and cancer development [60]. Motivated by these applications, chemotaxis and related phenomena
have received significant attention in the theoretical community, see the reviews [23, 24].
We suppose that in normal conditions (first part of the experiments described in Section 2,
where there is no treatment), tumour cells proliferate and move via chemotaxis as described before.
We suppose that cell proliferation is limited by the nutrients available in the environment, i.e. cell
proliferation is only active as long as the local density does not exceed a given threshold corresponding
to the carrying capacity of the environment. Moreover, in order to take into account the finite size
of cells and volume limitations, cell motion is only allowed in locations where the local cell density
is much smaller than another threshold value corresponding to the tight packing state. In normal
conditions, cells are supposed to behave as rigid bodies. In stressed conditions however, (second part
of the experiments described in Section 2) we suppose that cells respond to the chemotherapeutic
stress (induced by the presence of the treatment) by changing their mechanical properties and
behaving as a semi-elastic material.
These hypotheses are modelled via a system of partial differential equations (PDE) which corre-
sponds to a volume-filling chemotaxis equation [43] for the first part (to describe the self-organization
of cells into aggregates), and a “semi-elastic” volume-filling chemotaxis approach [56] for the second
part, when the treatment is introduced.
For convenience we denote the density of the population of cancer cells in the first part of the
experiments by u(x, t) and that of the second part by w(x, t). Here x ∈ Ω ⊂ R2 where Ω is a
bounded domain. The time t ∈ [0, T ] where T = T1 + T2 represents the total time corresponding
to the first and second parts. The main difference between these two populations is the change in
the elastic properties of the cells due to the presence of the treatment. If the concentration of the
treatment is zero, u(x, t) = w(x, t). Cells follow a biased random walk according to the distribution
of the chemoattractant of concentration c(x, t) that is secreted by the cells. We start by detailing the
different components of the mathematical models corresponding to the two parts of the experiments
described in Section 2.
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Logistic growth model for cell proliferation As previously described, in order to take into
account the nutrient-limited population growth, cell proliferation is modelled by a logistic growth
process. At the population level, we consider a source term f(u) in the PDE for the evolution of the
cell density which depends nonlinearly on the local cell density u and reads:
f(u) = ru
(
1− u
umax
)
. (1)
Here, r > 0 is the proliferation rate and umax corresponds to the maximum density of the population,
also referred to as the carrying capacity of the environment. Alternative cell kinetics could be con-
sidered. For example, we can assume that the proliferation is also mediated by the chemoattractant
concentration such that f(u, c) = ruc(1− u/umax) [43]. In this paper we focus on the case given by
(1).
Chemoattractant dynamics As described before, we suppose that cell aggregates spontaneously
emerge as the result of a self-organization phenomenon of chemotaxis type. To this aim, we suppose
that the cells themselves produce the signaling chemical (chemoattractant) that drives their motion.
The chemical secreted is therefore supposed to be continuously produced by the cells at rate α > 0
and diffuses in the surrounding environment with diffusion coefficient d2 > 0. It is further assumed
that the chemical has a finite lifetime and degrades at rate β > 0. The evolution of the chemical
concentration c(x, t) is therefore given by the following reaction-diffusion equation
∂tc = d2∆c+ αu− βc , (2)
where u is the cell density.
Treatment dynamics We suppose that the treatment is introduced at the beginning of P2. This
treatment is supposed to diffuse in the environment with diffusion coefficient d4, and to be consumed
by the cells at rate δ. This is modelled by a reaction-diffusion equation for the drug concentration
M(x, t):
∂tM = d4∆M − δw ,
where w(x, t) represents the cell density corresponding to the second part of the experiments. We
consider different initial conditions for the drug: either uniformly distributed in the simulation
domain, or introduced in the center as a very steep Gaussian function (see Section 5).
3.1 Volume-filling approach for chemotaxis: first part P1
The classical Keller-Segel system of equations [27] describes how cells move along the gradient to
local maxima of the chemoattractant. At the same time, this chemical, which is produced by the
cells, promotes aggregation leading to the so-called “overcrowding scenarios”, and eventually, the cell
density may blow up in finite time (see the comprehensive reviews [23, 50] and references therein).
In this paper, in order to take into account volume limitations and the finite cell size, we consider
a modified version of the Keller-Segel model called the volume-filling approach for cell motion. This
approach was introduced in [43], where the authors provided a detailed derivation in one dimension
as well as a comprehensive numerical study of the model.
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Figure 3: Squeezing probability for different values of γM for u¯ = 1.
Moreover, we introduce the so-called squeezing probability, which describes the probability that
a cell finds an empty space at a neighbouring location before moving (see [56]). It takes the form
q(u(x, t)) =
{
1−
(
u
u¯
)γM
, for 0 ≤ u ≤ u¯ ,
0, otherwise ,
(3)
where u(x, t) is the cell density, γM ≥ 1 is the squeezing parameter, M ≡ M(x, t) ≥ 0 denotes
the concentration of the treatment, and u¯ is the crowding capacity which corresponds to the tight
packing state of the cells. The function q(u) satisfies the following properties,
q(u¯) = 0 , 0 < q(u) ≤ 1 , and q′(u) ≤ 0 for 0 ≤ u < u¯ . (4)
Moreover, |q′(u)| is bounded and q′′(u) ≤ 0.
The exponent γM is chosen to be
γM = (γ¯ − 1)M + 1 , (5)
where γ¯ is a positive constant, M = 0 when there is no drug in the environment (part P1 of the
experiments), and M ≡ M(x, t) when the drug is introduced (part P2, described bellow). Such
choice of γM enables to take into account different forms of squeezing probability, corresponding
to different mechanical behaviors of the cells. In Figure 3, we plot the squeezing probabilities as
a function of the cell density, corresponding to different values of γM . We see that when there is
no treatment present in the environment (M = 0, γM = 1, blue curve of Figure 3), the squeezing
probability decreases linearly with the local cell density, corresponding to cells modelled as solid
particles.
However for larger values of γM (when the treatment is present, M > 0 and γM > 1, red and
yellow curves in Figure 3), the squeezing probability becomes a nonlinear function of the cell density,
modelling the fact that in the presence of a drug, cells change their mechanical state to behave as
semi-elastic entities that can squeeze into empty spaces. We refer to [55] for more details on the link
between the cells elastic properties and the squeezing probability.
For convenience of notation, we distinguish the case without treatment (M = 0) for P1 and
define
q1(u(x, t)) = 1− u
u¯
. (6)
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The Keller-Segel model built with this specific squeezing probability (6) has been widely studied in
the literature, from modelling [43, 55], analytic [58, 21, 32, 16] and numerical [26] perspectives.
Complete PDE system for the first part P1 Taking into account all the previous ingredients,
the complete PDE system for part P1 (when no treatment is present in the environment) reads:
∂tu = ∇ · (d1D1(u)∇u− χuφ1(u)∇c) + f(u) ,
∂tc = d2∆c+ αu− βc ,
(7)
where the first equation describes the evolution of the cell density u and the second is the reaction-
diffusion equation for the chemoattractant, previously introduced. The equation for u describes
the volume-filling chemotactic motion associated with the squeezing probability q1. This equation
has been obtained as the hydrodynamic limit of the continuous space-time biased random walk
model that corresponds to the squeezing probability q1 (see Appendix A for more details on the
derivation). In the hydrodynamic limit, the cell density evolves according to a nonlinear transport
diffusion equation with source term, which corresponds to a volume filling Keller-Segel model with
logistic growth. As shown in Appendix A, the density-dependent diffusion coefficient D1(u) and the
chemotactic sensitivity φ1(u) relate to q1 via
D1(u) = q1 − q′1u , φ1(u) = q1u .
For this part P1, where q1 is given by (6), these coefficients take the values D1 = 1 and φ1(u) = u(1−
u/u¯). In equation (7), d1, χu, α, β are all positive parameters (see Appendix A for the computation
of d1 and χu), and f(u) is the logistic growth source term previously mentioned and defined by (1).
The PDE system is supplemented with the following zero-flux boundary conditions
(d1D1(u)∇u− χuφ1(u)∇c) · η = 0 , d2∇c · η = 0 , (8)
where η is the outer unit normal at ∂Ω. The initial conditions are given by
u(x, 0) = u0 , c(x, 0) = c0 . (9)
3.2 PDE system including the treatment: Part P2
We now describe the dynamics of the cell population when the drug is introduced (part P2 of the
experiments described in Section 2). As previously mentioned in Section 2 and motivated by the
observations in [39], where the treatment TMZ does not seem to induce cell death, we suppose that
the drug only affects the elastic properties of the cells. For a cell density w(x, t) the squeezing
probability of part P2 is
q2(w(x, t),M) = 1−
(w
u¯
)γM
. (10)
Note that we have supposed that the crowding capacity u¯ which corresponds to the tight packing
state remains unchanged from P1 to P2. This corresponds to the hypothesis that the treatment
does not modify the volume of the cells but only change their elastic properties.
The complete PDE system corresponding to the second part of the experiments therefore reads:
∂tw = ∇ · (d3D2(w,M)∇w − χwφ2(w,M)∇c) + f(w) ,
∂tc = d2∆c+ αw − βc ,
∂tM = d4∆M − δw ,
(11)
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where f(w) is again the logistic growth source term given by (1), and the first equation has been
derived using the squeezing probability q2 defined by (10). Note that the carrying capacity umax
remains unchanged in the two parts of the experiments: we have supposed here that the drug does
not interact with the nutrients. Analogous to (7), the movement of the cells is described by a
chemotactic system where, in this case, the diffusion and chemosensitive coefficients depend also on
the concentration of the treatment. These modified coefficients will lead to changes in the size of the
aggregates as shown in the numerical experiments in Section 5. The evolution of the concentration
c is the same as in (7) where, in this case, the chemoattractant is produced by the new population
w. Including proliferation also in this second part allows us to assess the effect of the treatment in
the population at earlier times, while the population of cells is still growing and aggregates are still
forming.
Different initial conditions for the cell density and concentration of the treatment will be con-
sidered as described in Section 5. Each initial condition for P2 will correspond to a density profile
solution of the system P1 at a given time (solution of (16)), i.e. w(x, 0) = u(x, T1) for some given T1.
We will consider cases where the treatment is introduced on already formed and stable aggregates
(steady state of (16)), but also cases where it is introduced at earlier times (during the formation of
the aggregates, see Section 5). The initial condition for the concentration of the drug is considered
to be either homogeneously distributed in the simulation domain or introduced in the center.
Remark 3.1. In both parts of the experiments, we assume that the crowding capacity u¯ is larger
than the carrying capacity umax. The carrying capacity is defined as the maximum population density
beyond which there are not enough nutrients to support growth, while the crowding capacity describes
the maximum density in an aggregate depending on the space available.
4 Linear stability analysis and pattern formation
The system for part P1 (7) without source term is well known in the literature as the volume-
filling Keller-Segel model, for which emergence of patterns has been characterised and is now well
documented. Pattern formation refers to the phenomenon by which, after varying a bifurcation pa-
rameter, the spatially homogeneous steady state loses stability and inhomogeneous solutions appear.
In the following, we investigate in which parameter region we can expect instability of homogeneous
solutions, corresponding to the formation of patterns. The linear stability analysis followed here is
classical and follows the lines of [43, 56, 35].
We first recall the two systems associated with the dynamics described in parts P1 and P2 of
the model. Using the fact that in the first part of the experiments, the squeezing probability is
chosen to be q1(u) = 1− uu¯ , we have
∂tu = ∇ · (d1∇u− χuφ1(u)∇c) + ru
(
1− u
umax
)
,
∂tc = d2∆c+ αu− βc ,
(12)
where
D1 = 1 , and φ1(u) = u
(
1− u
u¯
)
. (13)
For part P2, when the squeezing probability function is given by (10), the system writes
∂tw = ∇ · (d3D2(w,M)∇w − χwφ2(w,M)∇c) + r˜w
(
1− w
umax
)
,
∂tc = d2∆c+ αw − βc ,
∂tM = d4∆M − δw ,
(14)
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with diffusion and chemotactic coefficients given by
D2(w,M) = 1 + (γM − 1)
(w
u¯
)γM
and φ2(w,M) = w
(
1−
(w
u¯
)γM)
. (15)
4.1 Dimensionless model
To get a deeper insight to the behaviour of the system we introduce the characteristic values of the
physical quantities appearing in the models. Denoting by X and T the macroscopic units of space
and time, respectively, such that x¯ = xX , t¯ =
t
T , then we choose
(x¯, t¯) =
(√
β
d2
x,
βd1
d2
t
)
.
Using these new variables, the dimensionless systems write for part P1
∂tu = ∇ · (∇u−Aφ1(u)∇c) + r0u
(
1− u
umax
)
,
ζ∂tc = ∆c+ u− c .
(16)
Similarly, we obtain for P2
θ∂tw = ∇ · (D2(w,M)∇w −Bφ2(w,M)∇c) + r˜0n
(
1− w
umax
)
,
ζ∂tc = ∆c+ n− c ,
m∂tM = ∆M − δ0w ,
(17)
where
A =
χu
d1
, r0 =
d2r
d1β
, ζ =
d1
d2
, θ =
d1
d3
, B =
χw
d3
, r˜0 =
d2r˜
d3β
, m =
d3
d4
, δ0 =
δ
d1
. (18)
The parameters ζ and m are assumed to be small since the chemoattractant and the chemother-
apeutic treatment diffuse faster than the cells. On the other hand, θ ' 1 since both population
densities u and w are assumed to be diffusing at similar rates. In the following, we state the linear
stability for both systems in separate sections.
4.2 First part: Formation of the aggregates
We first consider the system (16), which can be re-written in a more general form as
∂tu = ∇ · (∇u−Aφ1(u)∇c) + f(u) ,
ζ∂tc = ∆c+ g(u, c) ,
(19)
where φ1(u) is given in (13), f(u) = r0u(1 − uumax ) and g(u, c) = u − c. This system is subject to
uniformly distributed initial conditions and zero-flux boundary conditions as in (8).
The main result in this section is the following theorem, which gives the conditions for pattern
formation for the system (19).
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Theorem 4.1. Consider (u∗, c∗) a spatially homogeneous steady state. Then pattern formation
for the system (19) with zero flux boundary conditions (8) and initial data (9) is observed if the
following conditions are satisfied,
f∗u + ζ
−1g∗c < 0 , f
∗
ug
∗
c > 0 , ζ
−1g∗c + f
∗
u − ζ−1g∗uAφ1(u∗) > 0 ,
g∗c + f
∗
u + g
∗
uAφ1(u
∗) > 2
√
f∗ug∗c .
(20)
The critical chemosensitivity is given by
Ac =
2
√
r0 + 1 + r0
umax
(
1− umaxu¯
) , (21)
and for A > Ac patterns can be expected. The wavemodes k2 are in the interval defined by
k21 =
−m−√m2 − 4f∗ug∗c
2
< k2 < k22 =
−m+√m2 − 4f∗ug∗c
2
, (22)
where m = −(g∗c + f∗u + g∗uAφ1(u∗)).
Proof. See Appendix B for the proof of this theorem.
4.3 Second part: Treatment
We now consider the system (17) which corresponds to the second part of the experiments, when
the treatment is introduced. The parameter range where patterns are observed is summarised in
the following theorem.
Theorem 4.2. Consider (w∗, c∗,M∗) a spatially homogeneous steady state. Also, consider (17)
with zero flux boundary conditions given by
(d3D2(w,M)∇w − χwφ2(w,M)∇c) · η = 0 , d2∇c · η = 0 , d4∇M · η = 0 ,
and initial conditions
w(x, 0) = u(x, T1) ,
c(x, 0) of P2 is equal to c(x, T1) from P1 ,
M(x, 0) =
{
constant in Ω , or
Ce
(x−x0)2
2σ2 ,
(23)
where C is the amplitude, x0 is the centre of the Gaussian and σ is the width. Then, the critical
chemosensitivity is given by
Bc =
2
√
r¯0D2(umax,Ms) +D2(umax,Ms) + r˜0
umax
(
1−
(
umax
u¯
)γMs) ,
where
D2(umax,Ms) = 1 + (γMs − 1)
(umax
u¯
)γMs
.
Patterns can be expected if B > Bc and the wavemodes k2 are in the interval defined by
k21 =
−m¯−√m¯2 − 4D2(umax,Ms)(f∗wg∗c )
2D2(umax,Ms)
< k2 < k22 =
−m¯+√m¯2 − 4D2(umax,Ms)(f∗wg∗c )
2D2(umax,Ms)
,
for m¯ = −(D2(umax,Ms)g∗c + g∗wBφ2(umax,Ms) + f∗w).
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Proof. The proof of this theorem can also be found in Appendix B.
Remark 4.1. For the case of 2 dimensions, we can rewrite the systems (16) and (17) using polar
coordinates (ρ, θ) where we use the transformation x = ρ sin θ, y = ρ cos θ and the Laplace operator
is now given by ∆p =
1
R
∂
∂ρ
(
ρ ∂∂ρ
)
+ ρ2 ∂
2
∂θ2 where R is the radius of the domain. The eigenvalue
problem (45) is now written as −∆pψk = k2ψk with boundary conditions ∂ψk/∂ρ = 0 at ρ = R.
The eigenfunctions are obtained by separation of variables and are given by ψk(x, y) = R(ρ)Θ(θ).
Here Θ(θ) = eisθ = A cos(sθ) + B sin(sθ) for some s ∈ Z. The radial part R(ρ) is given in terms
of Bessel functions R(ρ) = Js(kρ) (see [46]) where k = cs,pR and cs,p denotes the the pth zero
derivative of Js, which is a first kind Bessel function of order m. Finally we can write ψs,pk (ρ, θ) =
J ( cs,pR ρ) (A cos(sθ) +B sin(sθ)) .
The stability analysis reveals that several competing effects control the system’s ability to create
patterns (aggregates). The criteria obtained both in P1 or P2 show that the chemotactic sensitivity
must be large enough to compensate the smoothing effect of the diffusion term and of the logistic
growth. On the other hand, one can observe from the bifurcation formulae that the ratio umaxu¯
(carrying capacity vs density of the tight packing state) plays an important role in the emergence
of patterns: larger values lead to more aggregated states. These results show that the logistic
growth term has an intrinsic smoothing property, i.e., it tends to force the density to equate the
carrying capacity, while the chemotactic term acts as a attractive force and creates zones of higher
density (recall that umax < u¯). The aggregates are an expression of a balance in between these two
competing effects, which are completely characterised by the stability criterion.
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Figure 4: Wavenumbers for different values of γM when (a) r0 = 0.1, umax = u0 = 0.5; and for (b)
r0 = 0.05, umax = u0 = 0.1 . Circles indicate the values of kc.
In order to give more insights about the size of the emerging patterns, we show in Figure 4 the
values of the inverse of the maximal wavenumber as function of the chemotactic sensitivity (denoted
by A for part P1 and B for part P2), for different values of the exponent γM . We recall that γM = 1
in P1 (blue curve) where cells act as rigid bodies and γM > 1 in the presence of the treatment,
where cells behave as semi-elastic entities (P2). Figure 4a shows the results for growth rate r0 = 0.1
and carrying capacity umax = 0.5, Figure 4b for r0 = 0.05 (slower growth) and umax = 0.1 (lower
carrying capacity). In both figures, the black circles indicate the critical values for the chemotactic
sensitivity above which the system is unstable. Here, the tight packing density is set to u¯ = 1. The
maximal wavenumber corresponds to the most unstable mode, i.e. the perturbed wave that will
12
grow the fastest. Therefore, the inverse of this maximal wavenumber is directly related to the size
of the emerging patterns. As one can observe, an increase in the chemotactic sensitivity parameter
correlates with a decrease in the observed pattern size, suggesting that the aggregates are smaller:
larger chemotactic sensitivity leads to more aggregated clusters. Moreover, the aggregate size also
decreases as cells pass from rigid bodies to semi-elastic entities (when γM increases). This is due
to the fact that for larger values of γM , cells are more easily deformed and can aggregate more
efficiently than when they behave as rigid spheres.
When we increase the ratio umaxu¯ (compare Figure 4a and 4b), we observe that the critical value
of the chemosensitivity above which patterns are generated is larger than for smaller ratios umaxu¯ .
These results highlight once again the smoothing effect of the logistic growth: When the cell tight
packing density is unchanged, decreasing the carrying capacity of the environment enhances cell
death in the aggregates formed by chemotaxis, where cells try to reach the tight packing state. In
this case, the critical chemosensitivity value must be large enough to compensate for the cell death
induced by the logistic growth. Moreover, we observe that larger ratios umaxu¯ induce less influence of
the parameter γM . The cell aggregation abilities are mainly driven by the chemosensitivity intensity
and not so much by the cell mechanical properties for large values of umaxu¯ .
5 Numerical simulations
In addition to the analytic results obtained in Section 4, we present numerical simulations for the
two problems (16) and (17). This allows us to investigate the behavior of the solution of the models
for different scenarios and range of parameters. It is well-known that a standard discretization of
the Keller-Segel models can lead to nonphysical solutions due to the convective term. Here, we focus
on a numerical method that preserves the non-negativity of the cell density using the upwind finite
element method described in [10] for the simulation of the Cahn-Hilliard equation.
The calculation of the chemotactic coefficient follows the lines of [3]. Indeed, the finite volume
scheme proposed in [3] is identical to the numerical method presented in this paper in dimension
one. However, in higher dimensions, and since we also use a finite element method, the numerical
scheme presented in [3] differs from the one in this section as detailed in Appendix C.
5.1 Description of the scheme
The domain Ω is discretized by a mesh T h constituted of Nel piecewise linear finite elements. We
denote the total number of nodes by Nh and the standard P1 finite element space by Sh. The
standard L2 inner product is indicated by (·, ·) and the lumped scalar product defined in Appendix
C by (·, ·)h. Given NT ∈ N?, let ∆t := T/NT be the time-step where T is the time corresponding to
the end of the simulation. Let tn := n∆t, n = 0, . . . , NT −1 be the temporal mesh. We approximate
the continuous time derivative by ∂uh∂t ≈
un+1h −unh
∆t . We define
unh(x) :=
Nh∑
j=1
unj χj(x) , and c
n
h(x) :=
Nh∑
j=1
cnj χj(x) ,
the finite element approximations of the cell density u and the concentration of chemoattractant c
where {unj }j=1,...,Nh and {cnj }j=1,...,Nh are unknowns and {χj}j=1,...,Nh is the finite element basis.
Then, the finite element problem associated with the system (16) reads as follows.
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For each n = 0, . . . , NT − 1, find {un+1h , cn+1h } in Sh × Sh, such that for all χ ∈ Sh(
un+1h − unh
∆t
, χ
)h
+
(
D(unh)∇un+1h ,∇χ
)
=
(A (φupw(unh))∇cnh,∇χ) + r0
(
unh
(
1− u
n
h
umax
)
, χ
)h
, (24)
ζ
(
cn+1h − cnh
∆t
, χ
)h
= − (∇cn+1h ,∇χ)+ (un+1h − cn+1h , χ)h . (25)
The function φupw is defined by (76) in Appendix C. The finite element scheme associated with the
system (17) including the effect of the treatment is the following
θ
(
wn+1h − wnh
∆t
, χ
)h
+
(
D(wnh ,M
n
h )∇wn+1h ,∇χ
)
=
(
B
(
φ
upw
2 (w
n
h ,M
n
h )
)
∇cnh,∇χ
)
+ r˜
(
wnh
(
1− w
n
h
umax
)
, χ
)h
, (26)
ζ
(
cn+1h − cnh
∆t
, χ
)h
= − (∇cn+1h ,∇χ)+ (wn+1h − cn+1h , χ)h , (27)
m
(
Mn+1h −Mnh
∆t
, χ
)h
= − (∇Mn+1h ,∇χ)− δ (Mn+1h , χ)h . (28)
The method to compute the coefficient φ
upw
and the diffusion coefficient D(wnh ,M
n
h ) is the same as
for the problem (24)–(25) (see Appendix C).
5.2 Biological relevance of the model parameters
Here, we comment on the choice of the model parameters that we will use for the numerical simu-
lations and how they relate to experimental known data. In [19, 13], the proliferation rate for well
oxygenated glioma cells in vitro r was shown to lie between 0.5 and 1 day−1. As the proliferation
rate relies significantly on the nutrient, also smaller value seems to be biologically admissible in real
conditions and following [13] we choose r = 0.4 day−1 and r = 0.8 day−1 (corresponding to the
non-dimensionalised parameter r0 = 0.05 and r0 = 0.1). As hypoxia-inducible factors (HIF) are
supposed to be responsible for the chemotaxis motion of GBM cells, we suppose that the diffusion
coefficient d2 and consumption rate β for the chemoattractant are linked to biological measurements
of the oxygen diffusion in human brain which were estimated in [53, 19] to d2 = 86.4 mm
2 day−1
and β = 8640 day−1. However, we chose to consider slightly lower values d2 = 8.64 mm2 day−1 and
β = 864 day−1 owing to the large variability of this parameter according to the type of tissue (see
[52]). For such values and using the scaling of Section 4.1, one unit of time of our model corresponds
to approximately 0.1 day and one unit of space is 0.1 mm. As we found no experimental data on the
chemotactic coefficient χu of glioma cells in response to chemoattractant concentration, the choice
of this parameter is driven by the stability analysis and we find that the interesting regimes are
obtained for a dimensionless chemosensitivity in between 7 and 70, corresponding to a chemotac-
tic coefficient χu ∈ [0.6, 6] mm2 day−1. Moreover, as no measurements for glioma cells diffusion
coefficient are available in the literature, the parameter d1 is arbitrarily chosen to be 100 times
smaller than the chemoattratant diffusion speed and we choose d1 = d3 = 0.086 mm
2 day−1, i.e the
non-dimensionalised parameter ζ = d1d2 = 0.01.
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5.3 Numerical results for a one dimensional case
For all numerical computations we choose the packing capacity u¯ = 1. We consider different prolifera-
tion rates r0 = 0.1, 0.05 and different initial conditions and carrying capacities umax = u0 = 0.1, 0.5.
The nondimensional parameters given in (18) are ζ = m = 0.01 and θ = 1 since we assume that the
chemoattractant c and the treatment diffuse much faster than the cells, while the motility of the
cells is not affected by the treatment, so d1 ≈ d3. The initial condition for the cell density u0 is as-
sumed to be randomly distributed in space. Similarly, we can also define the initial chemoattractant
concentration c0.
In this section we start by solving the systems (16) and (17) on the interval [0, L] with homoge-
neous non-flux boundary conditions using the method described in Section 5.1. In Appendix D we
investigate the effect of the size of the domain as well as the effect of the parameters A and B on
the formation and evolution of patterns. Moreover, using (17) we study the effect of the treatment
using the solution of (16) at the final time T1 as initial condition. We explore the case when we
introduce the treatment at earlier stages of the formation of the aggregates.
We consider two different scenarios for the evolution of the concentration of the treatment. First,
we assume that the treatment diffuses very fast in the whole domain so that the concentration is
homogeneous from time T2 = 0. The other case we consider, which is closer to real experiments,
starts with a high concentration of the drug in the centre of the domain and this concentration
diffuses over time according to the third equation in (17).
Comparison with the linear stability analysis In order to quantify the aggregate sizes and
compare it to the ones predicted by the stability analysis, we use the Fourier transform of the
numerical solution and extract the frequency that corresponds to the maximal Fourier mode. For
the sake of this analysis, periodic boundary conditions are therefore considered. To this aim, we
compute the discrete Fourier transform F [u](x, t) = uˆ(λ, t) and define
kmax = arg max
λ
(|uˆ(λ)|) = arg max
λ
(√
Re(uˆ(λ))2 + Im(uˆ(λ))2
)
,
which corresponds to the frequency of the largest Fourier mode. The inverse (kmax)
−1
of this
maximal frequency relates to the pattern size. This maximal frequency of the Fourier transform
of the solution is expected to correspond to the maximal wavenumber predicted by the stability
analysis. We show in Figure 5 the values of (kmax)
−1
computed from the numerical solution (blue
dotted line) compared to the predictions of the stability analysis (red curve), as function of the
chemosensitivity, for γM = 1 (left figure) and γM = 5 (right figure). As one can observe, we obtain a
very good agreement between the numerical values and the predictions of the stability analysis, and
we recover the critical value of the chemosensitivity parameter above which the system generates
patterns.
Introduction of the treatment on already-formed aggregates In this part, we aim to study
the influence of the treatment on already formed aggregates. For this, we let the system run in P1
(without treatment, M = 0, γM = 1) until time T1 = 200 and introduce the treatment uniformly in
the domain (M = 1, γM = 5).
In Figure 6 left and middle panels, we choose values of the chemosensitivity very close to the
critical values corresponding to kc, where the wavenumbers are very different for the cases γM = 1
and γM = 5 as we see in Figure 4a. In Figure 6, the blue curves describe the formation of aggregates
for a time T1 = 200 without the treatment, while the cells are proliferating with rate r0 = 0.1. We
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Figure 5: Comparison of the wavelength obtained analytically, using (55) and (56), and numerically,
using the Fourier transform of the solution for (a) γM = 1 and (b) γM = 5.
consider two different scenarios when introducing the treatment: either cells stop proliferating (red
curves), or they continue with the same rate as before r0 = 0.1 (yellow curves).
When we introduce the treatment for values of A and B close to the instability threshold (A =
B = 7, left figure), we observe that the aggregates become steeper and the density in each aggregate
reaches the packing capacity u¯ = 1. This clearly leads to more compact aggregates as a result of
the nonlinearity introduced in (11) by the parameter γM . The main physical difference between
changing the parameter γM and changing the chemosensitivity coefficients A or B is the following.
By changing A or B depending on the concentration of the treatment, we are enhancing aggregation
over diffusion, essentially we are changing the motility of cells. By changing γM the motility, as well
as the elastic properties of the cells in the aggregates are affected. When we introduce the treatment
while cells keep proliferating, aggregates tend to merge together since the density is growing, as we
see in Figure 6 middle panel.
It is noteworthy that for large values of the chemosensitivity parameter (A = B = 70, right panel
in Figure 6), the treatment does not impact the aggregate dynamics. In this case, cell aggregation
is mainly driven by the chemotactic term and the cell mechanical properties have little influence.
These observations are in agreement with the stability analysis, which shows that the parameter γM
has more influence when the chemotactic sensitivity is close to the instability threshold.
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Figure 6: Aggregation pattern when A = B for A = 7 (left), A = 12 (middle) and A = 70 (right).
Blue curve: solution at T1 = 200 without treatment, red curves: solution at T = T1 + 200 when the
treatment is introduced uniformly with γM = 5 and proliferation is stopped, yellow curves: solution
with the same parameters as the red curves when proliferation goes on with r0 = 0.1.
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Finally, by comparing the red and yellow curves of Figure 6, it is clear that cell proliferation
has a major impact on the size of the aggregates. If the treatment has the double effect to stop
proliferation as well as modifying the cell mechanical properties, cell aggregates will become very
dense and well-separated, while merging aggregates are still observed if the treatment has the sole
effect to change the cell mechanical properties. Here, we chose to introduce the treatment at time
T1 = 200, we now aim to study the effect of the treatment introduced at different times in the
aggregation process.
Introduction of the treatment at different times Here, we consider the case when the treat-
ment is introduced at different times in the aggregation process. As before, we let the system run
in P1 (without drug, M = 0, γM = 1) until time t = T1 and introduce the treatment uniformly
in the domain (M = 1, γM = 5). We consider the cases when the treatment has the ability to
stop proliferation, and when the treatment only acts on the cell mechanical properties. In Figure 7,
we show the results at time T = T1 + 200 (red curve), when the treatment is introduced at times
T1 = 50 (left plots), T1 = 100 (middle plots) and T1 = 300 (right plots). Figures 7a show the results
when the treatment stops proliferation, Figures 7b when the treatment only changes the mechanical
properties of the cells. For each, the blue curves are the density profiles before introducing the treat-
ment. As one can observe, in Figures 7a and 7b, introducing the treatment at different times of the
aggregation process have a major impact on the size of the aggregated patterns formed at a latter
time. Introducing the treatment at an earlier time (T1 = 50, left figures) enables to obtain smaller
aggregates compared to when the treatment is introduced on already formed aggregates (T1 = 300,
right figures). This effect is more visible when the treatment has the double effect of blocking cell
proliferation and changing the elasticity (compare red curves in Figures 7a and 7b). In this case,
the earlier the treatment is introduced, the smaller the aggregated patterns. When the treatment
stops proliferation as well as the cell mechanical properties and is introduced at later times (right
panel of Figure 7a) we recover the observation of the real systems, where the treatment induces a
shrinking of the aggregate and favors the formation of more compact cell structures. This effect
is not observed when proliferation is active with the treatment, (right panel of Figure 7b) where
aggregates are merging and they are larger than before the treatment introduction. This suggests
indeed that the treatment has the double effect of blocking cell proliferation as well as changing the
cell mechanical properties. The model suggests that introducing the treatment at earlier times of the
tumour development could enable us to control the size and separation of the tumour aggregates.
Introduction of the treatment in the middle of the domain Finally, we aim to study the
case when the treatment is introduced in the center of the domain and diffuses in the environment.
Here we assume that the treatment is not consumed or escapes the domain, therefore δ0 = 0 in
(17). In Figure 8, we show the density profiles of the solution before introducing the treatment
(blue curves), and when the treatment is present (red curves), at times T2 = 0 (left), T2 = 5
(center) and T2 = 30 (right). The distribution of the treatment follows a Gaussian of the form
M(x, 0) = Ce
(x−x0)2
2σ2 , where C = 40 is the amplitude, x0 is the center of the Gaussian and σ = 0.5
describes the spread. As one can observe, the large concentration of the treatment in the middle
immediately sharpens the interface between already-formed aggregates, and favors the separation of
the cell clusters. As the treatment diffuses (middle figure), the clusters interfaces which sense a high
concentration of the treatment sharpen, creating denser and well-separated cell clusters.
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Figure 7: Introduction of the the treatment at different times T1 = 50, 100, 300 when u0 = 0.5 and
A = B = 12. The blue curves gives the initial condition for the part P2 of the experiment with the
treatment, represented by the red curve. (a) Without proliferation. (b) With proliferation, r0 = 0.1.
The red curves are at T = T1 + 200.
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Figure 8: Evolution of the pattern when the treatment is introduced in the center of the domain
with amplitude 40. The blue curves correspond to the solution without treatment at T1 = 200 and
the red curves are the solution with the treatment at T = T1 + 5 and T = T1 + 30.
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5.4 Numerical results for a two dimensional case
For the 2D simulations we consider that Ω is a disk of radius R which can be defined as Ω =
{(x, y) ∈ R2 : x2 + y2 < R2} where the boundary is given by ∂Ω = {(x, y) ∈ R2 : x2 + y2 = R2}.
The proliferation rate is chosen to be r0 = 0.05 and the initial homogeneous density as well as the
carrying capacity are set to umax = u0 = 0.1 or umax = u0 = 0.5. The other parameters can be
found at the beginning of Section 5.3.
In Figure 9 we show the formation of aggregates for different values of A without the treatment,
for u0 = 0.1 and r0 = 0.05. We observe that for A = 10 (Figure 9a) we do not have patterns, in
agreement with the analytic results obtained in Figure 7b since this value of A is less than Ac ≈ 16.7.
As we increase the chemosensitivity parameter, the aggregates become more compact. From Figure
9b we observe the phenomena of two aggregates merging together, analogous to the one dimensional
results in Figure 15. As expected, by changing the carrying capacity and the initial density of cells
to u0 = umax = 0.5, the patterns change shape. We observe a transition from spot-like patterns in
Figure 9 to maze-like structures in Figure 10. This behaviour has been widely studied experimentally
[41], numerically [34, 36] and more recently, also including a volume-filling approach [43].
(a) (b) (c)
Figure 9: Formation of aggregates at T1 = 200 when u0 = 0.1, r0 = 0.05 and (a) A = 10, (b) A = 20
and (c) A = 70.
(a) (b) (c)
Figure 10: Formation of aggregates at T1 = 200 without the treatment and when umax = u0 = 0.5,
r0 = 0.05 and (a) A = 7, (b) A = 12 and (c) A = 50.
Analogous to the one dimensional case, we consider two different initial conditions for the treat-
ment: (i) we first include the treatment uniformly in the domain with M = 5, and (ii) we introduce
the treatment in the middle of the domain and let it diffuses in space. In these simulations, the
treatment is supposed to block proliferation as well as changing the cell mechanical properties.
In order to compare the change in size of the aggregates before and after the treatment, we
compute the difference between the solution of the first part of the experiments u(x, T1) coming
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from (16), when the aggregates are formed (at T1 = 200), and the solution w(x, t) of (17), once
the treatment has been inserted (at time T = 200 + T2). In Figure 11, we show the results for
different values of the chemosensitivity parameter A = B, when the aggregates have been exposed
to a uniform distribution of the treatment for a time T2 = 30. We notice that the aggregates without
the treatment are bigger and therefore the treatment induces a shrinking in the size of the pattern, as
described in Section 3. When we compare the results in Figure 11a and 11b for different values of A
and B we observe that the effect of the treatment is stronger when the value of the chemosensitivity
parameter B is closer to its critical value (see Figure 4b). This is in accordance with the results of
the stability analysis. The cell mechanical properties (controlled by the parameter γM ) have less
influence on the cell cluster sizes when the chemosensitivity parameter A = B is increased (see
Figure 4b).
(a) (b)
Figure 11: Difference between the solutions u(x, 200) − w(x, 230) when (a) A = B = 20 and (b)
A = B = 70. Here γM = 11, r0 = 0.05 and umax = u0 = 0.1.
(a) (b) (c)
Figure 12: Difference between the solutions when the initial concentration of the treatment is a
Gaussian function centered in the domain. (a) T = 210, (b) T = 230 (c) T = 300 for T1 = 200,
r0 = 0.05 and u0 = 0.1.
We now study the case when the treatment is introduced in the middle of the domain and
diffuses in the environment. To this aim, the initial concentration of the treatment is supposed to
be a Gaussian function with width 5 centered in the middle of the domain. We assume that the
treatment is not consumed by the cells in the time scales we are interested in, and choose δ0 = 0. In
Figure 12 we show the evolution of the difference between the two solutions u(x, T1)−w(x, t), where
T1 = 200 is the time at which the treatment is introduced and T is the duration of the treatment.
We explore different times T2 = 10, 30, 100. For short times, the effect of the treatment is only
noticed by the aggregates at the center of the domain and therefore the difference between the two
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solutions close to the boundaries is zero. As time increases, the concentration of the treatment
reaches the whole domain as is observed in Figure 12c.
(a) (b) (c)
(d) (e) (f)
Figure 13: Effect of the treatment at different times while the aggregates are forming. Top row:
Cell aggregates for A = 20 without treatment at (a) T1 = 30, (b) T1 = 50 and (c) T1 = 100. Bottom
row: Cell aggregates at time T = T1 + 200, when the treatment has been introduced at times (d)
T1 = 30, (e) T1 = 50 and (f) T1 = 100.
Finally, we also study the effect of the treatment at earlier stages of the formation of the aggre-
gates. Figure 13 shows the different patterns obtained during the formation of the aggregates at
different times, top row, and the corresponding effect of the treatment, bottom row. For example,
introducing the treatment at T1 = 50 leads to a significant reduction of the size of the pattern with
a reasonably low concentration of the treatment. Identifying this specific time in real patients could
make the treatment much more effective and reduce the spread of the cancer cells.
6 Discussion of results and perspectives
In this paper we propose a mechanism for the effect of certain treatments on tumours formed by a
chemotaxis type self-organization phenomenon. Inspired by the experiments concerning the action of
TMZ on Glioblastoma cells mentioned in Section 2, we considered the particular case of treatments
that do not act as cytotoxic agents but rather induce stress in the environment, which may induce
changes in the mechanical properties of individual tumour cells by making them pass from rigid
bodies to semi-elastic entities. We explored two scenarios: a first one where only cell’s plasticity is
impacted by the treatment, and a second one where the treatment has a double effect of preventing
cell proliferation as well as changing cell mechanics.
Under these hypotheses, we obtained a modified version of the Keller-Segel model, known as the
nonlinear volume-filling approach for cell motion, where the cell mechanical properties are taken into
account in the form of the so-called squeezing probability. In the nonlinear volume-filling Keller-Segel
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model, this squeezing probability function could be related to the amplitude of the transport term
towards zones of high chemoattractant density (chemosensitivity), as well as with the (nonlinear)
diffusion coefficient.
By performing a linear stability analysis, we are able to detect and characterise the parameter
ranges for which the homogeneous distribution is unstable, i.e. the ranges for which patterns appear
as the result of the dynamics. We show that the emergence of patterns without treatment (i.e.
when cells act as rigid bodies) is driven by a fine interplay between the chemotactic sensitivity,
which tends to aggregate the cells, and the diffusion, together with the logistic growth, which tend
to smoothen the solution. We are able to compute the critical chemosensitivity value above which
the system self-organizes into aggregates, and characterise the size of the aggregates as a function
of the model parameters.
Under treatment, i.e. when cells behave as semi-elastic entities, we show that the critical value of
the chemosensitivity above which patterns emerge is smaller than that in control cultures, showing
that as cells become more elastic, they tend to aggregate more easily than when they behave as rigid
entities.
We are able to completely characterise the size of the patterns and show that semi-elastic cells
create smaller aggregates than rigid entities for the same value of the chemosensitivity. These results
suggest that the mechanical properties of individual cells have a huge impact on the shape and size
of the aggregated patterns at the population level.
Moreover, we show that the ratio between the tight packing cell density and the carrying capacity
of the TME plays a major role in the size and shape of the obtained patterns. For large values of
this ratio, the aggregation abilities of the system are essentially driven by the chemotactic transport
term while the individual cell mechanical behaviour has little impact on the shape and size of the
patterns. However, for smaller values of this ratio, i.e. when the tight packing density is closer to
the carrying capacity of the environment, cell mechanics has a huge influence on the behavior of the
population.
These results are confirmed by numerical experiments in 1D and 2D for which, given an initial
perturbation of the homogeneous cell distribution, we observe the emergence of cell aggregates
and we recover the critical values of the chemosensitivity predicted by the stability analysis. We
obtain a very good correspondence between the simulations and the theoretical predictions, for the
appearance of patterns as well as their size.
By performing simulations of the whole system, we recover the experimental observations: in-
troducing the treatment (TMZ in the experiments mentioned in Section 2) on already-formed ag-
gregates leads to the quick formation, of more compact patterns. As the treatment diffuses in the
domain (changing locally the cell mechanical properties as it goes), it sharpens the border of the
cell aggregates and leads to denser and well-separated clusters.
While the border sharpening of the clusters is independent on whether proliferation is activated
or not during treatment, the shrinking of the clusters is more clear when the treatment has the
double effect of changing the cell mechanical properties as well as blocking cell proliferation. Indeed,
when proliferation is still active in the presence of the treatment, we observe the merging of existing
clusters and this results in aggregates being larger than before treatment. These results suggest a
possible mechanism for the shrinking of the aggregates observed under the experimental conditions
described in Section 2: TMZ might not only stop cell proliferation, but might also generate a stress
in the environment to which cells respond to by changing their mechanical state.
While alterations of mechanical properties, around or inside the tumour, are common in solid
tumours including GBM, the question of the nature and the regulation of cancer cells through
mechano-sensitive pathways are largely unknown. Recently, in a Drosophila model, glioma pro-
gression has been associated to a regulatory loop mediated by the mechano-sensitive ion channel
22
Piezo1 and tissue stiffness [12]. A direct perspective of these works consists in verifying the poten-
tial mechano-sensing effect of TMZ proposed in the present model, through direct measures in real
systems by studying the mechanical properties of individual GBM cells which have been exposed to
TMZ treatment. The targeting of mechano-sensitive pathways after TMZ treatment may provide
new therapeutic angles in GBM and in more general settings.
Moreover, it would be interesting to identify other clinical settings where the effects of the
treatment are similar to those of TMZ in GBM, and to check if the effects are due to changes in the
tumor cell properties corresponding to the general hypothesis of the model constructed in this work.
In the future, better quantitative comparison with experiments will allow for systematic choice
of parameters and validation of the mechanisms we propose here. From a biological point of view, a
natural sequel of this work consists in studying the coupled effect of TMZ and irradiation. Indeed,
even if TMZ alone seems not to suffice to decrease the tumour mass, the coupling of TMZ treatment
with irradiation has been shown to have more efficient effects than irradiation alone [48, 5, 54]. It
would also be interesting to introduce a second treatment with cytotoxic effects in this model, to
study whether the mechanical changes of individual cells induced by TMZ could explain the better
response of the system to irradiation treatments.
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A Derivation of the general model
The modified Keller-Segel system (7), including the squeezing probability (3) was derived in one
dimension in [43, 56] from a continuous-time and discrete-space random walk. In this appendix we
give a more general (and formal) derivation in Rn starting from a kinetic equation, analogous to
[40, 45]. For simplicity, we do not include cell proliferation in this derivation.
Let us consider a mesoscopic density h(x, t,v), where x ∈ Rn and v ∈ V = {x ∈ Rn : |x| = 1},
which evolution is described by the following kinetic equation
∂th+ v · ∇h = −ξ(c)h(x, t,v) + q(σ(x, t))
∫
V
T (v,v′, c)h(x, t,v′) dv′ . (29)
Equation (29) describes a so-called velocity jump model where, individuals moving in an almost
straight line, described by the left hand side, switch velocities after stopping. The right hand side
of (29) describes the density of cells that are stopping with a frequency ξ(c) =
∫
V
T (v′,v, c) dv′,
where the operator T (v,v′, c) gives the probability of a velocity jump from v′ to v. Note that the
cells change velocity also depending on the chemoattractant concentration c(x, t).
The second term in the right hand side represents the individuals that start a new trajectory
with a different velocity v′. Note that this term is multiplied by the squeezing probability q since
the change into a new velocity is also determined by the probability of finding a neighbouring space
available.
Now we introduce a parabolic scaling (x, t) 7→ (x¯/ε, t¯/ε2) into (29), where the bar denotes the
new variables and ε  1. Letting T (v,v′, c) be a small perturbation of a random turning event,
T (v,v′, c) = T0 + εT0T1(v′,∇c), we have, after dropping the bars,
ε2∂th
ε + εv · ∇hε = q|V |T0uε(x, t) + εqT0
∫
V
T1(v
′,∇c)hε(x, t,v′) dv′
− hε(x, t,v)T0|V | − εT0hε(x, t,v)|V |T1(v,∇c) , (30)
where
uε(x, t) =
1
|V |
∫
V
hε(x, t,v) dv . (31)
Dividing by ε we get
ε∂th
ε + v · ∇hε = T0
ε
(
quε(x, t)|V | − hε(x, t,v)|V |
)
+ T0
(
q
∫
V
T1(v
′,∇c)hε(x, t,v′) dv′ − hε(x, t,v)|V |T1(v,∇c)
)
. (32)
The leading order terms in (32), when ε→ 0, give h(x, t,v) = qu(x, t). Integrating with respect to
v ∈ V in (30) we obtain a macroscopic conservation equation
∂tu+∇ · j = 0 , (33)
where jε = 1ε|V |
∫
V
vhε(x, t,v) dv is the mean direction of the cells.
Finally, we have to obtain jε in terms of the macroscopic density uε. For that, we multiply (30)
by v and integrate in V to get
ε2|V |∂tjε +∇ ·
∫
V
v ⊗ vhε dv = −T0|V |2jε − |V |T0
∫
V
vT1(v,∇c)hε dv . (34)
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Letting hε(x, t,v) = qu+ εh⊥(x, t,v) +O(ε2) we obtain, in the limit as ε→ 0,
j =
− ∫
V
v ⊗ v dv
T0|V |2 ∇(qu)−
∫
V
vT1(v,∇c) dv
|V | uq . (35)
Substituting (35) into the conservation equation (33) we obtain
∂tu−∇ ·
(
d1∇(qu)− χ(c)uq
)
= 0 , (36)
where
d1 =
∫
V
v ⊗ v dv
T0|V |2 and χ(c) = −
∫
V
vT1(v,∇c) dv
|V | . (37)
Considering the squeezing probability function q(u) in (3) and using the chain rule for differen-
tiation, ∇(qu) = (q − q′u)∇u where q′ = dqdu we finally have, assuming χ(c) = χu∇c,
∂tu = ∇ · (d1(q − q′u)∇u− χuuq∇c)
= ∇ · (d1D(u)∇u− χuφ(u)∇c) . (38)
Remark A.1. With the choice (3) for the squeezing probability, the diffusion of the cells is enhanced(
dD(u)
du > 0
)
. This means that the elastic collisions of the cells may increase, locally, the random
motion component.
B Stability analysis
First part of the experiments We first observe that the homogeneous distributions u(x, t) = u∗
and c(x, t) = c∗ are steady-states solutions of system (16) for u∗ and c∗ such that f(u∗) = 0 and
g(u∗, c∗) = 0. In order to study their stability, we consider the system without spatial variations
∂tu = f(u) , ζ∂tc = g(u, c) , (39)
and linearize the solution at (u∗, c∗). We obtain
∂tσ = Gσ , where σ =
(
u− u∗
c− c∗
)
and G =
(
f∗u 0
ζ−1g∗u ζ
−1g∗c
)
, (40)
where the quantities f∗u , g
∗
u and g
∗
c are the linearization slopes of f and g: f
∗
u = f
′(u∗), g∗u =
∂ug(u
∗, c∗), g∗c = ∂cg(u
∗, c∗). The steady state is linearly stable if tr(G) < 0 and det(G) > 0, which
imposes the following constraints on the kinetic functions f(u) and g(u, c),
f∗u + ζ
−1g∗c < 0 and f
∗
ug
∗
c > 0 . (41)
Note that in our case, f∗u = −r0, g∗u = 1, g∗c = −1 so the conditions are satisfied.
We now go back to the full chemotactic system (19). In order to investigate the stability of the
homogeneous steady-state, i.e. the ability of the system to create patterns, we introduce a small
parameter ε 1 and write
u = u∗ + εu˜(x, t) , c = c∗ + εc˜(x, t) . (42)
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We substitute (42) into (19) and, computing the first order terms with respect to ε and neglecting
higher order terms, the linearized system reads
∂tu = ∆u−Aφ1(u∗)∆c+ uf∗u + cf∗c ,
ζ∂tc = ∆c+ ug
∗
u + cg
∗
c ,
(43)
where φ1(u
∗) = u∗q1(u∗). We now look for perturbations of the form
u(x, t) =
∑
k
ak(t)ψk(x) and c(x, t) =
∑
k
bk(t)ψk(x) , (44)
where (ψk)k≥1 is an orthonormal basis of L2(Ω) and satisfies the following spatial eigenvalue problem
−∆ψk = k2ψk , ∂ψk
∂η
= 0 . (45)
Then, the linearized system (43) can be written as
∂t(ak) = −akk2 +Aφ1(u∗)bkk2 + akf∗u + bkf∗c ,
ζ∂t(bk) = −bkk2 + akg∗u + bkg∗c ,
(46)
where k is the spatial eigenfunction, also called the wavenumber and 1/k is proportional to the
wavelength ω. In matrix form we can write (46) as ∂tXk(t) = Pk(t)Xk(t) where
Xk =
(
ak
bk
)
, Pk =
(−k2 + f∗u Aφ1(u∗)k2 + f∗c
ζ−1g∗u ζ
−1(−k2 + g∗c )
)
. (47)
Remark B.1. Since the solutions of the eigenvalue problem (45) are simply sines and cosines, the
“size” of various spatial patterns is measured by the wavelength of the trigonometric functions. For
example, in one dimension when 0 < x < L, ψ ∝ cos(npix/L) and the wavelength is ω = 1/k = L/npi,
where n ∈ Z.
If the matrix Pk has eigenvalues with positive real part, then the homogeneous steady state
(u∗, c∗) is unstable, resulting in pattern formation. The characteristic polynomial related to (47) is
given by `2 + a(k2)`+ b(k2) = 0 where
a(k2) = (1 + ζ−1)k2 − (f∗u + ζ−1g∗c ) , (48)
b(k2) = ζ−1k4 − ζ−1(g∗c + f∗u + g∗uAφ1(u∗))k2 + ζ−1f∗ug∗c . (49)
The eigenvalues ` determine the temporal growth of the eigenmodes, and we require Re(`(k2)) > 0
for the homogeneous steady state to be unstable. Note that we only look for the eigenmodes k 6= 0
since we already guaranteed that the steady state is stable in the absence of spatial perturbations,
i.e. Re(`(k2 = 0)) < 0 in (41).
From the conditions (41), we know that a(k2) > 0, hence the instability can only occur if
b(k2) < 0 for some k so that the characteristic polynomial has one positive and one negative root.
This implies
k4 − (g∗c + f∗u + g∗uAφ1(u∗))k2 + f∗ug∗c < 0 . (50)
We also know from (41) that f∗ug
∗
c > 0, then a necessary (but not sufficient) condition for b(k
2) < 0
is
g∗c + f
∗
u + g
∗
uAφ1(u
∗) > 0 .
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Remark B.2. The bifurcation between spatially stable and unstable modes occurs when the critical
expression bmin(k
2
min) = 0 is satisfied.
Moreover, to satisfy (50) the minimum bmin must be negative [35]. Differentiation with respect
to k2 in (49) leads to
bmin(k
2
min) = −
(g∗c + f
∗
u + g
∗
uAφ(u
∗))2
4
+ f∗ug
∗
c . (51)
Hence, the condition bmin < 0 implies
g∗c + f
∗
u + g
∗
uAφ1(u
∗) > 2
√
(f∗ug∗c ) . (52)
To summarise, we have obtained the following conditions for the generation of spatial patterns
for the chemotaxis system (19),
f∗u + ζ
−1g∗c < 0 , f
∗
ug
∗
c > 0 , ζ
−1g∗c + f
∗
u − ζ−1g∗uAφ1(u∗) > 0 ,
g∗c + f
∗
u + g
∗
uAφ1(u
∗) > 2
√
f∗ug∗c .
(53)
From the analysis in this section, and using the particular forms of φ1(u), f and g as in (19),
it is easy to see that the spatially homogeneous steady states are (0, 0) and (umax, umax). We
can check that (0, 0) is an unstable steady state, therefore we only work with (umax, umax) which,
on the contrary, is stable. The first and second properties in (53) are immediately satisfied, i.e.,
−(r0 + ζ−1) < 0 and r0/ζ > 0, respectively. Finally, we have to check that the third and fourth
conditions are satisfied as well. We have that
− 1− r0 +Aφ1(u∗) > 2√r0 . (54)
Therefore, (54) is a necessary condition for pattern formation for the original system (12). Consid-
ering A as a bifurcation parameter, we can obtain a critical value Ac, so that we observe pattern
formation if A > Ac. From (54) we get
Ac =
2
√
r0 + 1 + r0
umax
(
1− umaxu¯
) . (55)
The corresponding critical wavenumber k2c is obtained from (51) using (54) as follows,
k2c =
g∗c + f
∗
u + g
∗
uA
cφ1(u
∗)
2
=
√
f∗ug∗c =
√
r0 . (56)
This means that, within the unstable range, Re(`(k2)) > 0 has a maximum wavenumber given by
k2c . The range of linearly unstable modes k
2
1 < k
2 < k22 is obtained from b(k
2) = 0,
k21 =
−m−√m2 − 4f∗ug∗c
2
< k2 < k22 =
−m+√m2 − 4f∗ug∗c
2
, (57)
where m = −(g∗c + f∗u + g∗uAφ1(u∗)).
Second part of the experiments Following the same steps as before we linearise the system
(17) to get
∂tw = D2(w
∗,M∗)∆w −Bφ2(w∗,M∗)∆c+ wf∗w ,
ζ∂tc = ∆c+ wg
∗
w + cg
∗
c ,
m∂tM = ∆M − δ0w ,
(58)
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where
D2(w
∗,M∗) = 1 + (γ∗M − 1)
(w∗
u¯
)γ∗M
, φ2(w
∗,M∗) = w
(
1−
(w∗
u¯
)γ∗M)
,
and γ∗M is given by (5) evaluated at M
∗. As in (44), we let
w(x, t) =
∑
k
ak(t)ψk(x) , c(x, t) =
∑
k
bk(t)ψk(x) , M(x, t) =
∑
k
ck(t)ψk(x) , (59)
where ψk(x) satisfies (45) and we obtain a system ∂tXk(t) = Pk(t)Xk(t) where
Xk =
akbk
ck
 , Pk =
−D2(w∗,M∗)k2 + f∗w Bφ2(w∗,M∗)k2 01
ζ g
∗
w
1
ζ (−k2 + g∗c ) 0
− δ0m 0 − 1mk2
 . (60)
Similar to the previous section, the characteristic polynomial is given by a(k2)`3 +b(k2)`2 +c(k2)`+
d(k2) = 0 where a(k2) = −1 and
b(k2) = −
(
D2 +
1
ζ
+
1
m
)
k2 + f∗w +
g∗c
ζ
, (61)
c(k2) = −
(D2
ζ
+
D2
m
+
1
mζ
)
k4 +
(g∗cD2
ζ
+
g∗c
ζm
+
f∗w
ζ
+
f∗w
m
+
g∗wBφ2
ζ
)
k2
− f
∗
wg
∗
c
ζ
, (62)
d(k2) = −D2
mζ
k6 +
1
mζ
(D2g
∗
c + g
∗
wBφ2 + f
∗
w)k
4 +
1
mζ
(−f∗wg∗c )k2 . (63)
In general, the stability analysis for this cubic polynomial will require the Ruth–Hurwitz stability
criterion [25] which states that the steady state is unstable if the coefficients of a(k2)`3 + b(k2)`2 +
c(k2)`+ d(k2) = 0 satisfy the condition
1
(a(k2))2
(
b(k2)c(k2)− a(k2)d(k2)) < 0 .
However, from (60) we observe that one of the eigenvalues of the matrix Pk is given by `1 =
−k2
m < 0.
The remaining two eigenvalues can be computed from the upper-left matrix(−D2(w∗,M∗)k2 + f∗w Bφ2(w∗,M∗)k2
1
ζ g
∗
w
1
ζ (−k2 + g∗c )
)
, (64)
following the same analysis as for the case without TMZ.
The characteristic polynomial `2 + a¯(k2)`+ b¯(k2) = 0 related to (64) has coefficients
a¯(k2) =
(
D2(w
∗,M∗) +
1
ζ
)
k2 − f∗w −
g∗c
ζ
, (65)
b¯(k2) =
D2(w
∗,M∗)
ζ
k4 −
(D2(w∗,M∗)g∗c
ζ
+
Bφ2(w
∗,M∗)g∗n
ζ
+
f∗w
ζ
)
k2
+
f∗wg
∗
c
ζ
. (66)
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For the steady state to be unstable we require, as before, that Re(`(k2)) > 0. Since a¯(k2) > 0 the
instability can only occur if b¯(k2) < 0. Computing db¯(k
2)
dk2 = 0 from (66) we obtain
k2min =
D2(w
∗,M∗)g∗c + g
∗
wBφ2(w
∗,M∗) + f∗w
2D2(w∗,M∗)
. (67)
Hence from the condition b¯min(k
2
min) < 0 we get
D2(w
∗,M∗)g∗c + g
∗
wBφ2(w
∗,M∗) + f∗w >
√
4D2(w∗,M∗)f∗wg∗c . (68)
The spatially homogeneous steady state is (w∗, c∗, M∗) = (umax, umax, Ms), where
Ms = |Ω|−1
∫
Ω
M(x, 0) dx. Therefore, from (68) we obtain a critical constant Bc so that for any
B > Bc we observe pattern formation. This critical constant is given by
Bc =
2
√
r¯0D2(umax,Ms) +D2(umax,Ms) + r˜0
umax
(
1−
(
umax
u¯
)γMs) , (69)
where
D2(umax,Ms) = 1 + (γMs − 1)
(umax
u¯
)γMs
. (70)
The corresponding critical wavemode is given by
k2c =
D2(umax,Ms)g
∗
c + g
∗
wB
cφ2(umax,Ms) + f
∗
w
2D2(umax,Ms)
=
√
D2(umax,Ms)(f∗wg∗c )
D2(umax,Ms)
. (71)
Finally, the unstable modes are k2 < k2c , where from b¯(k
2) = 0 we get
k21 =
−m¯−√m¯2 − 4D2(umax,Ms)(f∗wg∗c )
2D2(umax,Ms)
< k2 < k22
=
−m¯+√m¯2 − 4D2(umax,Ms)(f∗wg∗c )
2D2(umax,Ms)
, (72)
for m¯ = −(D2(umax,Ms)g∗c + g∗wBφ2(umax,Ms) + f∗w).
C Description of the numerics
We denote H1(Ω) = W 1,2(Ω) the usual Sobolev space and the standard L2 inner product is denoted
by (·, ·). Let T h, h > 0, be a quasi-uniform mesh of the domain Ω consisting of N disjoint piecewise
linear mesh elements K such that the discretized domain Ωh =
⋃
K∈T h K. Let hK := diam(K) and
h = maxK hK and for d = 2, we choose linear triangular elements. In addition, we assume that the
mesh is acute i.e. for d = 2, each angle of the triangles can not exceed pi2 . We must stress that for
d = 2 since the domain Ω is circular, a small error of approximation is committed using Ωh. We
consider the standard finite element space associated with T h
Sh := {χ ∈ C(Ω) : χ∣∣
K
∈ P1(K), ∀K ∈ T h} ⊂ H1(Ω) , (73)
where P1(K) denotes the space of first-order polynomials on K. Let Nh be the total number of nodes
of T h, Jh the set of nodes and {xj}j=1,...,Nh their coordinates. We call {χj}j=1,...,Nh the standard
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Lagrangian basis functions associated with the spatial mesh. We denote by pih : C(Ω) → Sh the
standard Lagrangian interpolation operator We also need the lumped scalar product to define the
problem
(η1, η2)
h =
∫
Ω
pih (η1(x)η2(x)) dx ≡
∑
xj∈Jh
(1, χj)η1(xj)η2(xj) , η1, η2 ∈ C(Ω) .
We define the standard mass and stiffness finite element matrices as G and K, where
Gij =
∫
Ω
χiχj dx, for i, j = 1, . . . , Nh ,
Kij =
∫
Ω
∇χi∇χj dx, for i, j = 1, . . . , Nh .
In the following finite element approximation of the Keller-Segel problem, the mass matrix is lumped,
i.e. the matrix becomes diagonal with each term being the row-sum of the corresponding row of the
standard mass matrix,
Gl,ii :=
Nh∑
j=1
Gij , for i = 1, . . . , Nh .
In order to describe how the chemotactic coefficient φuwp is computed, let us rewrite the discrete
equation (24) into its matrix form
(GL + ∆tKD)u
n+1 = GLu
n + ∆tKφc
n + ∆tGLg
n ,
where un and cn are the vectors of coefficients which are the unknowns of the problem and gn is a
vector defined by [
gn
]
i
=
(
unh
(
1− u
n
h
umax
))
(xi) , for i = 1, . . . , Nh .
We define the finite element matrices associated with the diffusion KD and the advection Kφ
KD,ij =
∫
Ω
D(unh)∇χi∇χj dx for i, j = 1, . . . , Nh , (74)
Kφ,ij =
∫
Ω
φupw (unh(xi), u
n
h(xj))∇χi∇χj dx for i, j = 1, . . . , Nh . (75)
In (74), the integral is computed using Gauss quadrature to deal with a potential choice of nonlinear
functional for D(unh). The exactness of the quadrature is obtained using the adequate number of
Gauss points since D(unh) is a polynomial of order γM + 1.
The chemotactic coefficient is computed using an upwing approach. For each element and de-
pending on the direction of the gradient of the chemoattractant we have
φupw (unh(xi), u
n
h(xj)) =
u
n
h(xj)
(
1−
(
unh(xi)
u
))
, if cnh(xj)− cnh(xi) < 0,
unh(xi)
(
1−
(
unh(xj)
u
))
, otherwise.
(76)
Therefore, the chemotactic coefficient is chosen as function of the sign of the difference of chemoat-
tractant between nodes connected by an edge. The property of non-negativity of the cell density
satisfied by our numerical scheme can be proved using similar arguments as in [10].
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D One dimensional numerical results
Influence of the domain size The unstable wavenumbers are discrete values, k = npi/L, that
satisfy the relation (57) from Section 4.2. The wavemode n determines the number of aggregates
depending on the length of the domain. For A = 7 and the parameters specified at the beginning
of this section we have 0.25 < npi/L < 0.4. As shown in Figure 14, as we increase the length of the
domain, the number of aggregates also increases. When the domain is large, as in Figure 14c, we
observe that some aggregates are merging together while others are emerging, i.e., they are formed
from a zone of low cell density. This process is called coarsening [43] and is not observed in a small
domain such as in Figure 14a.
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Figure 14: Relationship between the wavenumber k and the length of the domain L for A = 7.
For the remaining simulations in this section we fix the length of the domain to L = 40, and all
simulations are performed with carrying capacity umax = 0.5.
Comparison of the results with the stability analysis predictions Here, we study the
influence of the chemosensitivity parameter A on the pattern dynamics and size of the aggregates,
in the presence or absence of TMZ. In order to compare the solutions to the predictions of the stability
analysis, the initial condition is a small perturbation around the homogeneous distribution u0 = 0.5.
Results of this section are obtained with a proliferation rate r0 = 0.1. For such parameters, using the
results of Section 4, the critical value of the chemosensitivity parameter without the treatment (in
P1, when M = 0 and therefore γM = 1 ) is A
c ≈ 6.92 and with the treatment uniformly distributed
(for γM = 5) is B
c ≈ 3.9.
In the first part of the experiment, i.e. without any treatment, we show in Figure 15 the
formation of patterns at different times, for A = 7 (close to the instability threshold, Figure 15a),
A = 50 (Figure 15b) and A = 150 (Figure 15c). We observe here the process of merging and
emerging patterns through time.
As predicted by the stability analysis, larger values of the chemotactic sensitivity A favor the
emergence of smaller aggregates (compare Figures 15a and 15c for A = 7 and A = 150, respectively).
This is due to the fact that for larger chemotactic sensitivity, cells are more attracted to zones of
high concentration of chemoattractant. The creation of patterns instead of the expansion of a
homogeneous cell distribution is due to an instability which results from a positive feedback loop
between the production of the chemical by the cells on one hand, and their attraction to high density
zones of this chemical on the other. The chemotactic sensitivity A must be large enough to trigger
this instability, in order to compensate the competing effects of diffusion and of the logistic growth
term, which on the contrary, tends to regulate the local cell density to the carrying capacity of the
environment umax, and therefore induces cell death inside the aggregated patterns for which the
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Figure 15: Formation of the pattern without the treatment for (a) A = 7, (b) A = 50 and (c)
A = 150 when r0 = 0.1 and umax = u0 = 0.5.
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density is above umax.
When the drug is introduced uniformly in the domain starting from a homogeneous distribution
of cells (i.e. for M = 1, γM = 5) at time t = 0, we show in Figure 16 the formation of patterns at
different times, for chemosensitivity B = 5 (close to the instability threshold, Figure 16a), B = 30
(Figure 16b) and B = 150 (Figure 16c). Note that in this case we also let cells to proliferate with
rate r0 = 0.1.
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Figure 16: Formation of the pattern with treatment (M = 1, γM = 5), included at t = 0 when
u0 = 0.5, r0 = 0.1 for (a) B = 5, (b) B = 30 and (c) B = 150.
As one can see in Figure 16, we first observe again that increasing the chemosensitivity parameter
B results in the formation of smaller cell aggregates (compare Figures 16a and 16b). Very close to
the instability threshold (Figure 16a), the system converges quickly to one aggregate, while for larger
values of B (Figure 16c) a large number of well-separated small aggregates arises. These clusters
merge in time to form bigger clusters as for the case without the treatment. Moreover, comparing
Figures. 15c and 16c, we clearly observe that varying the mechanical state of cells (i.e. passing from
γM = 1 to γM = 5), leads to a change in the cell’s aggregate size. When cells are more elastic, they
tend to create smaller aggregates than when they behave as rigid spheres.
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